Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome

View source ↗

Summary

A completed clinical trial evaluating osilodrostat for the treatment of Cushing's syndrome has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isturisa (osilodrostat)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Cushing's Syndrome | Status: COMPLETED | Results posted: 2025-02-10